285 related articles for article (PubMed ID: 32971151)
41. Attitude, complications, ability of fasting and glycemic control in fasting Ramadan by children and adolescents with type 1 diabetes mellitus.
Deeb A; Al Qahtani N; Akle M; Singh H; Assadi R; Attia S; Al Suwaidi H; Hussain T; Naglekerke N
Diabetes Res Clin Pract; 2017 Apr; 126():10-15. PubMed ID: 28189949
[TBL] [Abstract][Full Text] [Related]
42. Summer-winter switching of the Ramadan fasts in people with diabetes living in temperate regions.
Ghouri N; Gatrad R; Sattar N; Dhami S; Sheikh A
Diabet Med; 2012 Jun; 29(6):696-7. PubMed ID: 22060294
[No Abstract] [Full Text] [Related]
43. Perceptions among Muslims regarding fasting, medication use and provider engagement during Ramadan in the United States.
Alshehri AM; Barner JC; Wong SL; Ibrahim KR; Qureshi S
Int J Health Plann Manage; 2021 May; 36(3):945-957. PubMed ID: 33711183
[TBL] [Abstract][Full Text] [Related]
44. Safety and tolerability of Empagliflozin use during the holy month of Ramadan by fasting patients with type 2 diabetes: A prospective cohort study.
Samkari MM; Bokhari NS; Alhajaji R; Ahmed ME; Al Raddadi A; Bahget AK; Saleh SF; Aljehani F; Alzahrani SH; Alsifyani SS; Samkari MM; Badr AF; Alalawi M; Al Sulaiman K
Saudi Pharm J; 2023 Jun; 31(6):972-978. PubMed ID: 37234349
[TBL] [Abstract][Full Text] [Related]
45. Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM).
Lessan N; Hannoun Z; Hasan H; Barakat MT
Diabetes Metab; 2015 Feb; 41(1):28-36. PubMed ID: 25497966
[TBL] [Abstract][Full Text] [Related]
46. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study.
Salti I; Bénard E; Detournay B; Bianchi-Biscay M; Le Brigand C; Voinet C; Jabbar A;
Diabetes Care; 2004 Oct; 27(10):2306-11. PubMed ID: 15451892
[TBL] [Abstract][Full Text] [Related]
47. Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach.
Mbanya JC; Al-Sifri S; Abdel-Rahim A; Satman I
Diabetes Res Clin Pract; 2015 Aug; 109(2):226-32. PubMed ID: 26003888
[TBL] [Abstract][Full Text] [Related]
48. A survey of fasting practices and acceptance of an intervention for achieving control in diabetes during Ramadan.
Dabral S; Mukherjee S; Saha N; Manjavkar S; Kohli S
Natl Med J India; 2020; 33(1):5-9. PubMed ID: 33565478
[TBL] [Abstract][Full Text] [Related]
49. The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study (DAR-MENA T2DM).
Hassanein M; Al Awadi FF; El Hadidy KES; Ali SS; Echtay A; Djaballah K; Dessapt-Baradez C; Khazaal FAK; Abu-Hijleh MO; Al Shaikh A; Gharbi MEH; Shehadeh N; Bennakhi A; Al Arouj M
Diabetes Res Clin Pract; 2019 May; 151():275-284. PubMed ID: 30825560
[TBL] [Abstract][Full Text] [Related]
50. Diabetes and Ramadan: review of the literature.
Benaji B; Mounib N; Roky R; Aadil N; Houti IE; Moussamih S; Maliki S; Gressier B; El Ghomari H
Diabetes Res Clin Pract; 2006 Aug; 73(2):117-25. PubMed ID: 16647781
[TBL] [Abstract][Full Text] [Related]
51. Effectiveness of contextual education for self-management in Thai Muslims with type 2 diabetes mellitus during Ramadan.
Susilparat P; Pattaraarchachai J; Songchitsomboon S; Ongroongruang S
J Med Assoc Thai; 2014 Aug; 97 Suppl 8():S41-9. PubMed ID: 25518292
[TBL] [Abstract][Full Text] [Related]
52. Sulphonylureas in the management of type 2 diabetes during the fasting month of Ramadan.
Zargar A; Basit A; Mahtab H
J Indian Med Assoc; 2005 Aug; 103(8):444-6. PubMed ID: 16363203
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of physicians' approaches for the management of patients with diabetes during Ramadan in Iraq.
Alabbood M; Alameri R; Alsaffar Y
Diabetes Res Clin Pract; 2023 Jan; 195():110188. PubMed ID: 36442547
[TBL] [Abstract][Full Text] [Related]
54. The current state of knowledge, perception and practice in diabetes management during fasting in Ramadan by healthcare professionals.
Zainudin SB; Hussain AB
Diabetes Metab Syndr; 2018 May; 12(3):337-342. PubMed ID: 29305048
[TBL] [Abstract][Full Text] [Related]
55. Evidence-based risk factors for major complications during Ramadan fasting in people with diabetes grouped under IDF-DAR risk categories.
Rahmatullah ; Ahmedani MY; Basit A; Zia S; Hasan I; Masroor Q; Shaikh A; Khan J; Iqbal W
Diabetes Res Clin Pract; 2022 Mar; 185():109234. PubMed ID: 35124097
[TBL] [Abstract][Full Text] [Related]
56. Community pharmacists' knowledge of diabetes management during Ramadan in Egypt.
Amin ME; Chewning B
Int J Clin Pharm; 2014 Dec; 36(6):1213-21. PubMed ID: 25253679
[TBL] [Abstract][Full Text] [Related]
57. Management of diabetes during Ramadan: practical guidelines.
Sunni M; Brunzell C; Nathan B; Moran A
Minn Med; 2014 Jun; 97(6):36-8. PubMed ID: 25029798
[TBL] [Abstract][Full Text] [Related]
58. [Management of diabetes during Ramadan].
Alsalim W
Lakartidningen; 2022 Feb; 119():. PubMed ID: 35233757
[TBL] [Abstract][Full Text] [Related]
59. Risk of diabetic ketoacidosis during Ramadan fasting: A critical reappraisal.
Beshyah SA; Chowdhury TA; Ghouri N; Lakhdar AA
Diabetes Res Clin Pract; 2019 May; 151():290-298. PubMed ID: 30836132
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
